Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
January 8, 2024
January 8, 2024
January 8, 2024
January 3, 2024
December 11, 2023
December 11, 2023
December 11, 2023
December 4, 2023
November 14, 2023
November 9, 2023
November 7, 2023